Concepedia

Maurie Markman

MM

Statistics

Publications

17

Citations

774

H-Index

15

Active since

1991

Affiliations

Cleveland Clinic(Current)

Cleveland Foundation

Roswell Park Comprehensive Cancer Center

Gynecologic Oncology Group

Abington Memorial Hospital

Maurie Markman is an author at Cleveland Clinic specializing in medicine, oncology, and gynecologic oncology.

Publications per year

1991–2005

17

Publications

17

Phase 2 Trial of Liposomal Doxorubicin (40 mg/m2) in Platinum/Paclitaxel-Refractory Ovarian and Fallopian Tube Cancers and Primary Carcinoma of the Peritoneum

Maurie Markman, Alexander Kennedy, Kenneth Webster et al. · Gynecologic Oncology · 2000 · 159 citations

Medicine, Oncology, Pharmacology +12

Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study.

Maurie Markman, Mark F. Brady, Nick M. Spirtos et al. · Journal of Clinical Oncology · 1998 · 141 citations

Medicine, Oncology, Surgery +13

Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II Trial

Maurie Markman, John A. Blessing, David A. Moore et al. · Gynecologic Oncology · 1998 · 68 citations

Medicine, Oncology, Pharmacology +11

Phase 2 Evaluation of Topotecan Administered on a 3-Day Schedule in the Treatment of Platinum- and Paclitaxel-Refractory Ovarian Cancer

Maurie Markman, Alexander Kennedy, Kenneth Webster et al. · Gynecologic Oncology · 2000 · 57 citations

Medicine, Oncology, Pharmacology +12

Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials

Maurie Markman, Keith A. Webster, Kristine Zanotti et al. · Gynecologic Oncology · 2004 · 57 citations

Medicine, Oncology, Pharmacology +17

1–5 of 17